Léčivé přípravky pro zažívací trakt a metabolismus - REVESTIVE II.
Economic Operator with Whom the Contract Has Been Concluded
Show detail | ||||||||
---|---|---|---|---|---|---|---|---|
12717128 | 08/28/2020 | Takeda Pharmaceuticals Czech Republic s.r.o. | 18,225,900.00 | 16,569,000.00 | CZK |
Published Documents
Show detail | |||||
---|---|---|---|---|---|
363_Písemná zpráva.pdf | Písemná zpráva zadavatele | 09/07/2020, 04:57 PM | Dokument není zavirovaný | ||
363_Písemná zpráva.pdf | Písemná zpráva zadavatele | 02/28/2023, 03:30 PM | Dokument není zavirovaný |
List of Participants
Show detail | |||||||
---|---|---|---|---|---|---|---|
Takeda Pharmaceuticals Czech Republic s.r.o. | 26,490,060.00 | CZK |
Price Actually Paid in Each Year of Performance
12717128 | 2024 | 1,484,280.53 | 1,349,345.94 |
12717128 | 2023 | 1,736,215.19 | 1,578,377.42 |
12717128 | 2022 | 1,715,343.96 | 1,559,403.60 |
12717128 | 2021 | 3,205,297.26 | 2,913,906.60 |
12717128 | 2020 | 437,085.00 | 397,350.00 |